Neurological Research · 2018 · 61 citations · 19 references
MedicineOncologySurgeryNeuro-oncologyOncologic SurgerySurgical OncologyCancer BiomarkersCancer Survival AnalysisGlioblastomaInflammatory BiomarkersPreoperative Oncology AssessmentTumor GradingClinical Grading SystemsGlioblastoma BiomarkersGlioblastoma PrognosisGlioma GradingImmune Biomarkers In CancerKarnofsky Performance StatusNeutrophil-to-lymphocyte RatioPrognostic Value Of Grade
BACKGROUND: Neutrophil-lymphocyte ratio (NLR) is a simple, low-cost and easily measured inflammation marker, corresponding with pathological tumor grading and clinical prognosis in various cancers. OBJECTIVES: This study aimed to investigate the relationship between preoperative NLR and glioma grading and also the correlation between NLR and glioblastoma survival. METHODS: The preoperative NLR was analyzed retrospectively in 239 gliomas of different grades, and receiver operating characteristic (ROC) curve analysis was adopted to investigate the prediction of glioma grading. Univariate and multivariate analyses were performed to analyze the variables of overall survival (OS) of glioblastoma patients. RESULTS: There were significant differences in the preoperative NLR values among the four glioma groups, with the highest values observed in the glioblastoma group (p < 0.05). ROC curve analysis showed the NLR value of 2.36 was a cutoff point for predicting glioblastoma. The OS of patients with high NLR (≥ 4.0) was shorter compared with that with low NLR (< 4.0) (mean 11.23 vs. 18.56 months, p < 0.05). Univariate analysis and multivariate analysis indicated age≥ 60, NLR≥ 4.0, Karnofsky Performance Scores (KPS) ≤ 70, incomplete tumor resection, incomplete Stupp protocol accomplishment and the isocitrate dehydrogenase 1 (IDH1) wild-type as independent prognostic indicators for poor outcome (each p < 0.05). CONCLUSION: The preoperative NLR was correlated with glioma grading, and the elevated NLR was an independent predictive factor for poor outcome of glioblastoma patients. Abbreviation IDH1: Isocitrate dehydrogenase 1IL-8: Interleukin-8KPS: Karnofsky Performance ScoresNLR: Neutrophil-lymphocyte ratioOS: Overall survivalROC: Receiver operating characteristicSD: Standard deviationsWHO: World Health Organization.
19
Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma
Roger Stupp, Warren Mason, Martin J. van den Bent et al. · New England Journal of Medicine · 2005 · 21.6K citations · Full text
Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer
Stewart R. Walsh, Emily J. Cook, F. Goulder et al. · Journal of Surgical Oncology · 2005 · 1.1K citations · Full text
Medicine, Hematology, Oncology +16
Hematogenous dissemination of glioblastoma multiforme
Carolin Müller, Johannes Holtschmidt, Martina Auer et al. · Science Translational Medicine · 2014 · 327 citations
Medicine, Neurosurgery, Oncology +12
Neutrophil infiltration into human gliomas
Gianluca Fossati, Giovanni Ricevuti, Steven W. Edwards et al. · Acta Neuropathologica · 1999 · 226 citations
Medicine, Immunology, Oncology +14